Investing $24 billion to develop prototype vaccines for all 26 viral families that cause human disease is a critical step in protecting public health. By being proactive, we can prevent future pandemics and save countless lives. This investment not only safeguards our health but also strengthens our economy by reducing the long-term costs associated with disease outbreaks.